期刊文献+

融合蛋白TOP_3原核表达载体的构建、表达及纯化研究

Construction,expression and purification of fusion protein TOP_3 in prokaryotic expression system
下载PDF
导出
摘要 目的:利用HIV病毒TAT蛋白转导结构域、人缺氧诱导因子1α氧依赖降解结构域以及CASPASE3构建融合蛋白的原核表达载体,并在大肠杆菌中表达及纯化。方法:分别构建原核表达质粒pET-28a(+)-TAT、pET-28a(+)-TAT-ODD、pET-28a(+)-TAT-ODD-CASPASE3(pET-28a(+)-TOP3);在大肠杆菌BL21(DE3)pLysS内,利用镍-亚硝胺乙酸-组氨酸(Ni-NTA-His)亲和层析法对重组蛋白TOP3进行纯化。结果:成功构建了pET-28a(+)-TOP3的原核表达载体,经过优化表达和纯化条件,融合蛋白在IPTG诱导下获得特异性表达,纯化得到了高纯度的目的蛋白。结论:融合蛋白TOP3的成功表达及纯化,为该融合蛋白应用于肿瘤的治疗研究奠定了理论基础。 Objective:To construct a prokaryotic expression vector for a fusion protein, TAT protein transduetion domain (PTD).the ODD domain of hypoxia inducible factor1α(HIF-1α) and cysteinyl aspartatespecific protease 3, and then express and purify the fusion protein. Methods :The expression plasmids pET-28a (+)-TAT, pET-28a ( + )-TAT-ODD, pET-28a ( + )-TAT-ODD-CASPASEs (pET-28a ( + )-TOP3 ) were constructed respectively, and pET-28a (+)-TOP3 was transformed into E coll. BL21 (DE3)pLysS strain to be induced by IPTG. The obtained proteins were analyzed by SDS-PAGE. The fusion protein was purified with Ni- NTA-His affinity chromatography. Results: The recombinant plasmids were constructed successfully. The objective fusion protein was obtained by optimizing the conditions for expression and purification. Conclusion: The successful expression and purification of the fusion protein TOP3 has laid the foundation for using it to studing tumor therapy.
出处 《陕西医学杂志》 CAS 2009年第9期1142-1145,共4页 Shaanxi Medical Journal
基金 青海大学医学院中青年教师科研项目基金资助项目(2005-KJ-06)
关键词 诱导融合蛋白质类/代谢 原核细胞/代谢 载体蛋白质类/代谢 Viral fusion proteins/metabolism Prokaryotic cells/metabolism Carrier proteins/ metabolism
  • 相关文献

参考文献9

  • 1Nagahara H, Vocero-Akbani A M, Snyder EL, et al. Transduction of full length TAT fusion proteins into mammalian cells: TAT-p27Kipl induce cell migration [J]. Nature Med, 1998 , 4 (12) .1449-1452.
  • 2Tasciotti E, Zoppe M, Giacca M. Transcellular transfer of active HSV21 thymidine kinase mediated by an 11- amino-acid peptide from HIV-1 TAT [J]. Cancer Gene Ther , 2003 , 10(1) .64-74.
  • 3Bruick RK, McKnight SL. A conserved family of prolyl- 4-hydroxylases that modify HIF. [J] Science, 2001, 10 (3) : 1337-1340.
  • 4Huang LE, Gu J, Schau M, et al. Regulation of hypoxia-inducible factor 1 alpha is mediated by an O2- dependent degradation domain via the ubiquitin- proteasome pathway [J]. Proc Natl Acad Sci USA, 1998, 95(14) . 7987-7992.
  • 5Page EL, Chan DA, Giaccia A J, et al. Hypoxia- inducible factor-1 {alpha } stabilization in nonhypoxic conditions: role of oxidation and Intracellular ascorbate depletion. Mol Biol Cell, 2007,10(3) : 156-158.
  • 6Schwart SM. Cell death and the caspase cascade [J] Circulation, 1998,97: 227-229.
  • 7Chauhan A, Tikoo A, Kapur AK, et al. The taming of the cell penetrating domain of the HIV Tat: myths and realities [J]. Control Release, 2007,117 (2) : 148-162.
  • 8张生军,刘敏丽,魏晓丽,袁江涛.胃癌组织中Survivin、Caspase3、FHIT的表达及临床意义[J].陕西医学杂志,2007,36(11):1485-1487. 被引量:4
  • 9佟晓光,张颐,刘云鹏,郭科军.缺氧诱导因子-1α的表达与卵巢浆液性癌生物学行为的相关性[J].陕西医学杂志,2008,37(6):660-662. 被引量:2

二级参考文献10

  • 1戚基萍,张春庆,李丹阳.Survivin在反应性和肿瘤性星形胶质细胞中的表达及意义[J].临床与实验病理学杂志,2006,22(2):178-181. 被引量:1
  • 2闫琳,陈伟强,梁永钜,戴春岭,王晓红,石智,陈黎明,符立梧.沉默survivin基因介导口腔表皮癌细胞KB及KBv200凋亡的比较研究[J].癌症,2006,25(8):933-940. 被引量:11
  • 3Ting-Ting Wang Xiao-Ping Qian Bao-Rui Liu.Survivin:Potential role in diagnosis,prognosis and targeted therapy of gastric cancer[J].World Journal of Gastroenterology,2007,13(20):2784-2790. 被引量:42
  • 4[1]Harris AL.Hypoxia-a key regulatory factor in tumour growth.Nat Rev Cancer,2002,2 (2):38-47.
  • 5[2]Zhong H,De-Marzo AM,Laughner E,et al.Overexpression of hypoxia -inducible factor 1 alpha in common human cancers and their metastases.Cancer Res,1999,59(22):5830-5835.
  • 6[3]Wong C,Weilman TL,Lounsbury KM.VEGF and HIF-lalpha expression are increased in advanced stages of epithelial ovarian cancer.Gynecol Oncol,2003,91 (3):513-51:7.
  • 7[4]Nakayama K,Kanzaki A,Hata K,et al.Hypoxia-inducible factor 1 alpha (HIF-lalpha) gene expression in human ovarian carcinoma.Cancer Lett,2002,176 (2):215-223.
  • 8[5]Hidekatsu N,Yoh W,Haruhiko U,et al.Hypoxia inducible factorl-αexpression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancer.Cancer Lett,2007,251(1):164-167.
  • 9[6]Kitada T,Seki S,Sakaguchi H,et al.Clinicopathological significance of hypoxia inducible factor-1 alpha expression in human pancreatic carcinoma.Histopathology,2003,43(6):550-555.
  • 10[7]Ravi R,Mookerjee B,Bhujwalla ZM,et al.Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 alpha.Gene Dev,2000,14 (1):34-44.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部